Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +24.57%
#2 aelf aelf +21.73%
#3 Bitway Bitway +21.43%
#4 Pons Pons +14.64%
#5 Starpower Starpower +13.58%
#6 Decred Decred +13.13%
#7 TRIA TRIA +12.68%
#8 Wrapped STX (Velar) Wrapped STX (Velar) +12.22%
#9 DAPPOS DAPPOS +9.61%
#10 Wibx Wibx +8.12%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
설정
언어
한국어
통화
USD
테마
Tvardi Therapeutics, Inc. Tvardi Therapeutics, Inc.

Tvardi Therapeutics, Inc.

TVRD
주식 순위 #30249
Tvardi Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages... Tvardi Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of novel, oral, and small molecule therapies targeting signal transducer and activator of transcription 3 (STAT3) to treat inflammatory and proliferative diseases with significant unmet need in the United States. The company's lead product candidates include TTI-101, which is in Phase 1b/2 clinical development stage for fibrosis-driven diseases with an initial focus on idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC); and TTI-109, an oral, small molecule STAT3 inhibitor which is in Phase-1 clinical trial stage. Tvardi Therapeutics, Inc. was founded in 2017 and is based in Sugar Land, Texas.
주가
$1.88
마지막 동기화: 2026-08-18
시가총액
$17.59M
변동 (1일)
0.81%
변동 (1년)
-92.40%
국가
US
거래 Tvardi Therapeutics, Inc. (TVRD)

카테고리

Healthcare
Tvardi Therapeutics, Inc. (TVRD)의 주가 이력
최고 종가: $1.83 (2026-08-01 기준)

최저 종가: $17.54 (2025-04-01 기준)
Tvardi Therapeutics, Inc.의 주가 이력 (2025 ~ 2026)
연간 주가 성과
연도 성과
2026 (TTM) 100.99%
2025 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $527.89 35.09%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $996.61 51.72%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $115.26 -20.82%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $735.86 6.07%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.06K -5.95%
KR